G
Market Data
$3.69+$0.22 (+6.34%)
GRCE · Last trade
Prev Close
$3.47
Range (30d)
$3.24 – $3.80
Recent Filings
- 10-Q/A215.9 KBGrace Therapeutics, Inc.Nov 17, 4:22 PM ET·0001140361-25-042491
- 8-K6.9 MBGrace Therapeutics, Inc.Nov 13, 8:01 AM ET·0001140361-25-041807
- 10-Q5.2 MBGrace Therapeutics, Inc.Nov 13, 7:31 AM ET·0001140361-25-041804
- 8-K184.6 KBGrace Therapeutics, Inc.Oct 23, 8:09 AM ET·0001140361-25-039020
- 8-K190.3 KBGrace Therapeutics, Inc.Sep 18, 8:43 AM ET·0001140361-25-035337
- 8-K169.5 KBGrace Therapeutics, Inc.Sep 12, 4:13 PM ET·0001140361-25-034845
- 8-K193.2 KBGrace Therapeutics, Inc.Aug 27, 8:08 AM ET·0001140361-25-032847
- 8-K322.6 KBGrace Therapeutics, Inc.Aug 12, 8:00 AM ET·0001140361-25-030400
- 10-Q5.1 MBGrace Therapeutics, Inc.Aug 12, 7:31 AM ET·0001140361-25-030398
- 8-K191.0 KBGrace Therapeutics, Inc.Jun 25, 8:19 AM ET·0001140361-25-023557
Insiders
10- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Boily Jean-FrancoisVICE-PRESIDENT, FINANCE
- Canan JohnDirector
- Carter Roderick NoelDirector
- D'Alvise JanelleDirector, PRESIDENT & CEO
- D'Andrea CarrieVP Clinical Operations
- DAVIS A BRIANDirector
- DelAversano Robert JPrincipal Financial Officer
- Derby MichaelDirector
Tickers
Addresses
business
103 CARNEGIE CENTER SUITE 300
PRINCETON, NJ, 08540
mailing
103 CARNEGIE CENTER SUITE 300
PRINCETON, NJ, 08540
Former Names
- Acasti Pharma Inc.2024-10-25